Management of donor-specific antibodies in allogeneic hematopoietic cell transplantation: A retrospective single-center case-control study. (PubMed, Cell Transplant) - Sep 16, 2026 - "Depletion regimens included rituximab (n=12), bortezomib (n=10), daratumumab (n=2), intravenous immunoglobulins (n=6), plasma exchange (n=8), and immunoadsorption (n=9). Clinical outcomes did not differ significantly between DSA patients and controls. These real-world data underscore the importance of systematic DSA screening and multimodal depletion to optimize transplantation outcomes."
Journal • Retrospective data • Graft versus Host Disease • Immunology • Transplantation
|
|
Bernhard N Bohnert; Christoph Faul; Claudia Lengerke; Karina Althaus; Lennart Harland; Markus W Löffler; Sandra Hammer; Sarah Katzenstein; Semian L Schüch; Tamam Bakchoul; Wolfgang A Bethge
|